ER-Poor and HER2-Positive: A Potential Subtype of Breast Cancer to Avoid Axillary Dissection in Node Positive Patients after Neoadjuvant Chemo-Trastuzumab Therapy

PURPOSE: The study was to estimate the likelihood of axillary downstaging and to identify the factors predicting a pathologically node negative status after neoadjuvant chemotherapy (NAC) with or without trastuzumab in HER2-positive breast cancer. METHODS: Patients with HER2-positive, stage IIa-IIIc...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jian-wei, Mo, Miao, Yu, Ke-da, Chen, Can-ming, Hu, Zhen, Hou, Yi-feng, Di, Gen-hong, Wu, Jiong, Shen, Zhen-zhou, Shao, Zhi-ming, Liu, Guang-yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263615/
https://www.ncbi.nlm.nih.gov/pubmed/25504233
http://dx.doi.org/10.1371/journal.pone.0114646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263615/
https://www.ncbi.nlm.nih.gov/pubmed/25504233
http://dx.doi.org/10.1371/journal.pone.0114646

Ejemplares similares